Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LMP Vaccine in Advanced Solid Tumors
NCT06878612Phase 1Recruiting
- Start
- Apr 2025
- Primary completion
- Aug 2026
- Modality
- Nanoparticles, Cell Therapies, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 1, open-label trial of polyphenol whole tumor cell vaccine in solid tumor. Primary endpoint: Safety and tolerability. Started Apr 2025; status: recruiting.
02
Drugs
polyphenol whole tumor cell vaccine
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT06878612.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06878612.